Change of portfolio management team for SEB’s healthcare and biotech funds

SEB Investment Management informs investors that portfolio management of healthcare and biotechnology funds will be moved to another team in the fund management company as of 1 February 2021. Angelica Fatouros will be the portfolio manager for the funds.

Fatouros has extensive experience as pharmaceutical analyst and portfolio manager and has a PhD in pharmaceuticals. The funds will be managed based on a fundamental investment process where, among other things, analysis of the companies’ management and business model are key elements. Previously, the fund was managed based on a quantitative investment process.

Changes will take place in the following funds:

Detailed information is available at the following link: https://sebgroup.lu/ and upon request at the registered office of the Management Company.